Iantrek - About the company
Iantrek is a series C company based in White Plains (United States), founded in 2019 by Sean Ianchulev. It operates as a Developer of a minimally invasive eye surgery technology. Iantrek has raised $97.8M in funding from investors like USVP, Sectoral and Visionary Ventures. The company has 50 active competitors, including 5 funded and 10 that have exited. Its top competitors include companies like Alcon, Sight Sciences and Haag-Streit.
Company Details
Developer of a minimally invasive eye surgery technology. It offers an implantable biologic stent which is surgically implanted in tandem for increased aqueous outflow and lowering intraocular pressure.
Key Metrics
Founded Year
2019
Location
White Plains, United States
Stage
Series C
Total Funding
$97.8M in 4 rounds
Latest Funding Round
Ranked
3rd among 50 active competitors
Employee Count
81 as on Sep 30, 2026
Legal entities associated with Iantrek
Iantrek is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Iantrek, Inc. CIN: 83-4247121 , United States, Active | Dec 31, 2018 | - | - | - |
Sign up to download Iantrek's company profile
Iantrek's funding and investors
Iantrek has raised a total funding of $97.8M over 4 rounds. Its first funding round was on Aug 09, 2022. Its latest funding round was a Series C round on Apr 29, 2026 for $*****. 1 investor participated in its latest round. Iantrek has 7 institutional investors.
Here is the list of recent funding rounds of Iantrek:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 29, 2026 | 6846368 | Series C | 9385305 | 6625073 | 9549674 | 6414276 |
Aug 19, 2025 | 3397270 | Series C | 5714786 | 2221060 | 6133738 | |
Feb 14, 2025 | 8478024 | Series B | 7231586 | 3713687 | 7913624 | 3970287 |
View details of Iantrek's funding rounds and investors
Iantrek's founders and board of directors
Founder? Claim ProfileThe founders of Iantrek is Sean Ianchulev. Sean Ianchulev is the CEO of Iantrek.
Here are the details of Iantrek's key team members:
- Sean Ianchulev: Founder & CEO of Iantrek.
Iantrek's Board of Directors
Iantrek's board has 11 active members. Stephen Bloch, James Mazzo, Robert Weinreb, Marc-Andre Marcotte, Jeffrey K. Weinhuff, Tsontcho Ianchulev, Andrew Corley, Farrell Tyson, Jeffry K Weinhuff, Michael George Haydin, IV and Michael Haydin are independent board members.Here is the list of Iantrek's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 5y 11m | |
ucjdffd | Independent board member | - | Current | 6y 5m |
smoxxou | Independent board member | - | Current | 5y 8m |
tavsl{q | Independent board member | - | Current | 7y 8m |
mgawuco | Independent board member | - | Current | 3y 2m |
ijzuhji | Independent board member | - | Current | 3y 3m |
pyizrhi | Independent board member | - | Current | 2y 8m |
iqpmpt{ | Independent board member | - | Current | 4y 2m |
qhbiapi | Independent board member | - | Current | 6y 5m |
lxvqbtg | Independent board member | - | Current | 2y 1m |
aedusoi | Independent board member | - | Current | 2y 3m |
View details of Iantrek's Founder profiles and Board Members
Iantrek's employee count trend
Iantrek has 81 employees as of Sep 26. Here is Iantrek's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Iantrek's Competitors and alternates
Top competitors of Iantrek include Alcon, Sight Sciences and Haag-Streit. Here is the list of Top 10 competitors of Iantrek, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alcon 1945, Fort Worth (United States), Public | Developer of a wide range of eye care products | $187M | 70/100 | |
2nd | Sight Sciences 2006, Menlo Park (United States), Public | Developer of surgical systems for the treatment of ophthalmological diseases | $129M | 62/100 | |
3rd | Iantrek 2019, White Plains (United States), Series C | Developer of a minimally invasive eye surgery technology | $97.8M | 58/100 | |
4th | Haag-Streit 1858, Switzerland, Acquired | Manufacturer of ophthalmic diagnostic equipment and precision micro surgical instruments | - | - | 54/100 |
5th | Surgical equipment for anterior chamber Ophthalmic surgery | $31M | 42/100 | ||
6th | ![]() Zhitong Technology 2020, Jiaxing (China), Series A | Developer of surgical devices for ophthalmic indications | $13.7M | 35/100 | |
7th | X-BIOMEDICAL 2017, Wayne (United States), Seed | Revolutionizing microscopy with portable AI & VR systems for healthcare | - | - | 32/100 |
8th | Medicel 1996, Thal (Switzerland), Acquired | Developer of ophthalmic surgical instruments | - | - | 32/100 |
9th | Cutting Edge 2015, Montpellier (France), Funding Raised | Developer of ophthalmological products | - | 32/100 | |
10th | Epsilon Eye Care 1997, Mumbai (India), Unfunded | Manufacturer of ophthalmic precision surgical instruments | - | - | 31/100 |
Looking for more details on Iantrek's competitors? Click here to see the top ones
Iantrek's Investments and acquisitions
Iantrek has made no investments or acquisitions yet.
Reports related to Iantrek
Here is the latest report on Iantrek's sector:
News related to Iantrek
Media has covered Iantrek for a total of 4 events in the last 1 year, 2 of them have been about company updates.
•
Trinity Capital Provides $30MM in Growth Capital to IantrekABFJournal•Apr 29, 2026•Trinity Capital, Iantrek
•
Iantrek Announces Controlled Release of AlloSpan Canal Glaucoma Surgery PlatformEyewire•Mar 31, 2026•Iantrek
•
Iantrek Launches AlloFlo Uveo, Surgical Treatment Targeting Uveoscleral PathwayEyewire•Oct 15, 2025•Iantrek
•
Iantrek has filed a notice of an exempt offering of securities to raise $41,986,763.00 in New Funding.intelligence360•Sep 24, 2025•Iantrek
•
AP Iantrek Secures $42M Series C for AlloFlo™ Uveo Launch and Pipeline ExpansionBakersfield•Aug 20, 2025•Iantrek, Sectoral, Visionary Ventures, Civilization Ventures and 3 others
•
Iantrek Hits 2,000 Procedures for New Bio-Interventional Technology – AlloFlo™ UveoIantrek•May 06, 2025•Iantrek
•
Iantrek's glaucoma treatment shows positive safety and efficacy in improving eye fluid drainage.Eyewire•Mar 18, 2025•Iantrek
•
•
Iantrek's glaucoma treatment shows efficacy and safety in 2-year trial.GlobeNewswire•Mar 18, 2025•Iantrek
•
Are you a Founder ?
FAQs about Iantrek
Explore our recently published companies
- Bank of the West - East Orange based, 1973 founded, Unfunded company
- S. Middlesex FCU - Kentwood based, Unfunded company
- Muzeumluzyckie - Germany based, 2011 founded, Unfunded company
- SmartPod Technology - Bengaluru based, 2020 founded, Unfunded company
- Warbafdb - Uganda based, 2008 founded, Unfunded company
- Spksca - Schaumburg based, 1930 founded, Unfunded company

